Blog

Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024

Photo taken from Nermean Mostafa/LinkedIn

Oct 2, 2024, 23:57

Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024

Nermean Mostafa, Head of Clinical Oncology unit at Ain shams University, posted the following on LinkedIn:

“It was a great pleasure to actively participate in RTD Side Event during ESMO 2024 about the HCC patient journey. The meeting was a great opportunity to share insights and feedback from stakeholders, patient advocates groups, different members from international Liver communities networking with different representatives from international organizations and societies for better patient outcomes.”

Source: Nermean Mostafa/LinkedIn

cancer ESMO 2024 HCC patient journey international liver communities international organizations Nermean Mostafa networking OncoDaily Oncology patient advocate groups patient outcomes RTD Side Event stakeholder insights

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage